-
1Academic Journal
Συγγραφείς: Diana F. Gareeva, Irina A. Lakman, Alexander A. Agapitov, Liana F. Sadikova, Venera M. Timiryanova, Naufal Sh. Zagidullin, Диана Фирдависовна Гареева, Ирина Александровна Лакман, Александр Александрович Агапитов, Лиана Флоритовна Садикова, Венера Маратовна Тимирьянова, Науфаль Шамилевич Загидуллин
Συνεισφορές: Исследование выполнено при финансовой поддержке гранта РНФ 22-18-20123 «Методика оценки глобального экономического бремени болезни с учетом отдаленных последствий для здоровья и качества жизни населения (на примере новой коронавирусной инфекции)».
Πηγή: Complex Issues of Cardiovascular Diseases; Том 13, № 3S (2024): приложение; 16-26 ; Комплексные проблемы сердечно-сосудистых заболеваний; Том 13, № 3S (2024): приложение; 16-26 ; 2587-9537 ; 2306-1278
Θεματικοί όροι: Сердечно-сосудистые осложнения, sST2, hsTnI, VCAM-1, COVID-19, Long COVID-19, Cardiovascular outcome, Постковидный синдром
Περιγραφή αρχείου: application/pdf
Relation: https://www.nii-kpssz.com/jour/article/view/1422/929; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1422/1538; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1422/1539; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1422/1540; Ni W., Yang X., Yang D., Bao J, Li R, Xiao Y, Hou C, Wang H, Liu J, Yang D, Xu Y, Cao Z, Gao Z.Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care 2020; 24(1):422. doi:10.1186/s13054-020-03120-0.; Jirak P., van Almsick V., Dimitroulis D., Mirna M., Seelmaier C., Shomanova Z., Wernly B., Semo D., Dankl D., Mahringer M., Lichtenauer M., Hoppe U.C., Reinecke H., Pistulli R., Larbig R., Motloch L.J. Dexamethasone Improves Cardiovascular Outcomes in Critically Ill COVID-19, a Real World Scenario Multicenter Analysis. Front. Med. 9:808221. doi:10.3389/fmed.2022.808221; Shi S., Qin M., Shen B., Cai Y., Liu T., Yang F., Gong W., Liu X., Liang J., Zhao Q., Huang H., Yang B., Huang C. Association of CardiacInjury with Mortality in Hospitalized Patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802-810. doi:10.1001/jamacardio.2020.0950.; Lippi G., Lavie C.J., Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019(COVID-19): Evidence from a meta-analysis. Prog. Cardiovasc. Dis. 2020; 63(3):390-391. doi:10.1016/j.pcad.2020.03.001.; Zagidullin N., Motloch L.J., Gareeva D., Hamitova A., Lakman I., Krioni I., Popov D., Zulkarneev R., Paar V., Kopp K., Jirak P., Ishmetov V., Hoppe U.C., Tulbaev E., Pavlov V. Combining Novel Biomarkers for Risk Stratification of Two-Year Cardiovascular Mortality in Patients with ST-Elevation Myocardial Infarction. J Clin Med. 2020;9(2):550. doi:10.3390/jcm9020550.; Sánchez-Marteles M., Rubio-Gracia J., Peña-Fresneda N., Garcés-Horna V., Gracia-Tello B., Martínez-Lostao L., Crespo-Aznárez S., Pérez-Calvo J.I., Giménez-López I. Early Measurement of Blood sST2 Is a Good Predictor of Death and Poor Outcomes in Patients Admitted for COVID-19 Infection. J Clin Med. 2021, 10(16):3534. doi:10.3390/jcm10163534.; Rotoli B.M., Barilli A., Visigalli R., Ferrari F., Dall'Asta. Endothelial Cell Activation by SARS-CoV-2 Spike S1 Protein: A Crosstalk between Endothelium and Innate Immune Cells. Biomedicines. 2021, 9(9):1220. doi:10.3390/biomedicines9091220.; de Bruin S., Bos L.D., van Roon M.A., Tuip-de Boer A.M., Schuurman A.R., Koel-Simmelinck M.J.A., Bogaard H.J., Tuinman P.R., van Agtmael M.A., Hamann J., Teunissen C.E., Wiersinga W.J., Koos Zwinderman A.H., Brouwer M.C., van de Beek D., Vlaar A.P.J.; Amsterdam UMC COVID-19 Biobank Investigators. Clinical features and prognostic factors in Covid-19: A prospective cohort study. EBioMedicine. 2021, 67:103378. doi:10.1016/j.ebiom.2021.103378.; Antzelevitch C., Yan G.X., Ackerman M.J., Borggrefe M., Corrado D., Guo J., Gussak I., Hasdemir C., Horie M., Huikuri H., Ma C., Morita H., Nam G.B., Sacher F., Shimizu W., Viskin S., Wilde A.A.M. J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge. Europace. 2017; 19(4):665-694. doi:10.1093/europace/euw235.; Puntmann V.O., Carerj M.L., Wieters I., Fahim M., Arendt C., Hoffmann J., Shchendrygina A., Escher F., Vasa-Nicotera M., Zeiher A.M., Vehreschild M., Nagel E. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered from Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(11): 1265–1273. doi:10.1001/jamacardio.2020.4648.; National Guideline Centre (UK). Stroke and transient ischaemic attack in over 16s: diagnosis and initial management. London: National Institute for Health and Care Excellence (UK); 2019.; Thakur A., Kapil A., Deepti S. An Abnormal ECG Finding in a Patient With COVID-19. JAMA Intern Med. 2023;183(11):1261-1262. doi: 0.1001/jamainternmed.2023.2457.; Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19) версия 7 (03.06.2020). Режим доступа: http: //edu.rosminzdrav.ru/fileadmin/user_upload/specialists/COVID-19/MR_COVID-19_v7.pdf. (дата обращения 23.07.2024); Zagidullin N.S., Motloch L.J., Musin T.I., Bagmanova Z.A., Lakman I.A., Tyurin A.V., Gumerov R.M., Enikeev D., Cai B., Gareeva D.F., Davtyan P.A., Gareev D.A., Talipova H.M., Badykov M.R., Jirak P., Kopp K., Hoppe U.C., Pistulli R., Pavlov V.N. J-waves in acute COVID-19: A novel disease characteristic and predictor of mortality? PLoS ONE 16(10): e0257982. doi:10.1371/journal.pone.0257982.; Gutiérrez-Gutiérrez B., Del Toro M.D., Borobia A.M., Carcas A., Jarrín I., Yllescas M., Ryan P., Pachón J., Carratalà J., Berenguer J., Arribas J.R., Rodríguez-Baño J.; REIPI-SEIMC COVID-19 group and COVID@HULP groups. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: A multicenter cohort study. Lancet Infect. Dis. 2021; 21:783–792. doi:10.1016/S1473-3099(21)00019-0.; Jirak P., Fejzic D., Paar V., Wernly B., Pistulli R., Rohm I., Jung C., Hoppe U.C., Schulze P.C., Lichtenauer M., Yilmaz A., Kretzschmar D. Influences of Ivabradine treatment on serum levels of cardiac biomarkers sST2, GDF-15, suPAR and H-FABP in patients with chronic heart failure. Acta Pharm. Sin. 2018; 39(7):1189–1196. doi:10.1038/aps.2017.167.; Motloch L.J., Jirak P., Gareeva D, Davtyan P., Gumerov R., Lakman I., Tataurov A., Zulkarneev R., Kabirov I., Cai B., Valeev B., Pavlov V., Kopp K., Hoppe U.C., Lichtenauer M., Fiedler L., Pistulli R. and Zagidullin N. Cardiovascular Biomarkers for Prediction of in-hospital and 1-Year Post-discharge Mortality in Patients With COVID-19 Pneumonia. Front. Med. 2022;9:906665. doi:10.3389/fmed.2022.906665; Fiedler L., Motloch L.J., Jirak P., Gumerov R., Davtyan P., Gareeva D., Lakman I., Tataurov A., Lasinova G., Pavlov V., Hauptmann L., Kopp K., Hoppe U.C., Lichtenauer M., Pistulli R., Dieplinger A.M., Zagidullin N. Investigation of hs-TnI and sST-2 as Potential Predictors of Long-Term Cardiovascular Risk in Patients with Survived Hospitalization for COVID-19 Pneumonia. Biomedicines. 2022; 10;10(11):2889. doi:10.3390/biomedicines10112889.; Emdin M., Aimo A., Vergaro G., Bayes-Genis A., Lupon J., Latini R., Meessen J., Anand I.S., Cohn J.N., Gravning J., Gullestad L., Broch K., Ueland T., Nymo S.H., Brunner-La Rocca H.P., de Boer R.A., Gaggin H.K., Ripoli A., Passino C., Januzzi J.L.Jr. SST2 Predicts Outcome in Chronic Heart Failure Beyond NT-ProBNP and High-Sensitivity Troponin T. J. Am. Coll. Cardiol. 2018, 72(19):2309-2320. doi:10.1016/j.jacc.2018.08.2165.; Omland T., Pfeffer M.A., Solomon S.D., de Lemos J.A., Rosjo H., Benth J.S., Maggioni A., Domanski M.J., Rouleau J.L., Sabatine M.S., Braunwald E.; PEACE Investigators. Prognostic Value of Cardiac Troponin I Measured with a Highly Sensitive Assay in Patients with StableCoronary Artery Disease. J. Am. Coll. Cardiol. 2013, 61(12):1240-9. doi:10.1016/j.jacc.2012.12.026.; Haïssaguerre M., Derval N., Sacher F., Jesel L., Deisenhofer I., de Roy L., Pasquié J.L., Nogami A., Babuty D., Yli-Mayry S., De Chillou C., Scanu P., Mabo P., Matsuo S., Probst V., Le Scouarnec S., Defaye P., Schlaepfer J., Rostock T., Lacroix D., Lamaison D., Lavergne T., Aizawa Y., Englund A., Anselme F., O'Neill M., Hocini M., Lim K.T., Knecht S., Veenhuyzen G.D., Bordachar P., Chauvin M., Jais P., Coureau G., Chene G., Klein G.J., Clémenty J. Sudden cardiac arrest associated with early repolarization. N Engl J Med. 2008; 358(19):2016-23. doi:10.1056/NEJMoa071968.; Tikkanen J.T., Anttonen O., Junttila M.J., Aro AL, Kerola T, Rissanen HA, Reunanen A, Huikuri HV. Long-term outcome associated with early repolarization on electrocardiography. N Engl J Med. 2009; 361(26):2529-37. doi:10.1056/NEJMoa0907589.; Patel A., Getsos J.P., Moussa G., Damato A.N. The Osborn wave of hypothermia in normothermic patients. Clin Cardiol. 1994; 17(5):273–6. doi:10.1002/clc.4960170511.; Zorzi A., Migliore F., Perazzolo Marra, M., Tarantini G., Iliceto S., Corrado D. Electrocardiographic J waves as a hyperacute sign of Takotsubo syndrome. J Electrocardiol. 2012; 45(4): 353–356 doi:10.1016/j.jelectrocard.2012.04.004; Guo T., Fan Y., Chen M., Wu X., Zhang L., He T., Wang H., Wan J., Wang X., Lu Z. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(7):811–818. doi:10.1001/jamacardio.2020.1722.